Rowan Hillson Inpatient Safety Award 2022
Due to the pressure on hospital teams during the COVID pandemic, we postponed the 2021 competition but are now launching a revamped award for 2022 which has been amended to take into account the current COVID situation. We are inviting colleagues to submit entries which will be for:
Diabetes & Endocrinology Workforce Census 2022
We have now launched the annual census of Consultants in Diabetes and Endocrinology. This is being done on behalf of ABCD, SfE, Diabetes UK and The Royal College of Physicians London who are also project managing this census.
There has never been a more important time to gather information about how were all working and the impact our jobs have on our lives.
NCEPOD Transition study - young person and parent carer online survey
NCEPOD are undertaking a study to look at the process of transition from child to adult health services. As part of this study, they are collecting the views of young people and parent carers on the transition process via an online survey.
The link to share with any relevant patient/ parent groups is https://ncepod.qualtrics.com/jfe/form/SV_5t0grqVhJMWrzsW
The survey will be open until May 2022
ABCD publishes the results of the Integrated survey about diabetes services
Today, 17th December 2021, ABCD publishes the results of the Integrated survey about diabetes services.
https://bjd-abcd.com/index.php/bjd/article/view/781
Please find the link to the raw data of this survey below.
Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus
As of 25th October 2021, dapagliflozin 5mg is no longer authorised for the treatment of people with type 1 diabetes mellitus (T1DM) and should no longer be used in this population . This is based on AstraZeneca’s decision to remove the Type 1 diabetes indication for dapagliflozin 5mg.
ABCD are disappointed that the use of dapaglifozin has been withdrawn for people with type 1 diabetes.
This is not due to any safety concern for dapagliflozin in any indication, including people with type 1 diabetes.
Investigating the Impact of a Dedicated Diabetes-Stroke Multi-Disciplinary Team (D/S-MDT) on Patient Outcomes, Referrals and Staff Satisfaction
Raunak Chugani Chandiramani, Laura Storey, Mina Mansor, Neil Hill
Imperial College London
The rare occurrence of Type B insulin resistance syndrome (TBRIS) in a T1DM patient. Could an insulin pump be the solution?
Melvin Lee Yoong Zher, Andrew Pettit
Department of Diabetes and Endocrinology, Division of Internal Medicine, Airedale General Hospital
Flash blood glucose monitoring (Freestyle Libre) improves glycemic control and reduces hospital admissions for diabetic ketoacidosis and severe hypoglycemia in community dwelling people with type 1 diabetes receiving limited specialist care
Yin WL; Wong E; Moses J; Minton D; Hussain R; Obuobie K
oyal Gwent Hospital, Newport, Ysbyty Ystrad Fawr, General Practice; Aneurin Bevan University Health Board
Screening for gestational diabetes: Comparing NICE criteria vs. RCOG criteria recommended during the Covid pandemic – role of HbA1c in GDM screening
Varughese MS, Nayak AU
University Hospital of North Midlands NHS Trust, Stoke on Trent
